British Association of Dermatologists Guidelines for the Management of Hidradenitis Suppurativa (Acne Inversa) 2018

J.R. Ingram; F. Collier; D. Brown; T. Burton; J. Burton; M.F. Chin; N. Desai; T.E.E. Goodacre; V. Piguet; A.E. Pink; L.S. Exton; M.F. Mohd Mustapa


The British Journal of Dermatology. 2019;180(5):1009-1017. 

In This Article


The recommendations and discussions in the Linking Evidence to Recommendations (LETR, see Appendix C in Supporting Information) and consensus specialist experience were used to produce the management pathway for people with HS (Figure 1).

Figure 1.

Management pathway for people with HS. *Licensed for use in those aged 12 years and above. **Surgical interventions are relatively underrepresented in the management pathway because evidence of high quality, in the form of randomized controlled trials, is sparse. BP, blood pressure; DLQI, Dermatology Life Quality Index; HS, hidradenitis suppurativa; MDT, multidisciplinary team; NSAID, nonsteroidal anti-inflammatory drug; TDAP, thoracodorsal artery perforator; VAS, visual analogue scale